Harbour BioMed logo

Harbour BioMed

Healthy Life · Breakthrough Medicines

113 employees · est. 2016 · Cambridge, United States

VS
LabGenius Therapeutics logo

LabGenius Therapeutics

Combining human and machine intelligence to discover the next generation of therapeutic antibodies.

63 employees · est. 2012 · London, United Kingdom

LabGenius Therapeutics is the older company (2016 vs 2012).

Side-by-Side Comparison

Harbour BioMed LabGenius Therapeutics
Founded
2016 2012 older
Headquarters
Cambridge, United States London, United Kingdom
Employees
113 63
Industry
Biopharma, Biotechnology, Pharmaceutical AI, Biotechnology, Health and Wellness
Funding Stage
IPO Series B
Total Funding
$533.80M $63.66M
Funding Rounds
7 6
Services
Not tracked yet Therapeutic Antibody Discovery, Multispecific Antibody Development, AI and Machine Learning Integration
Target Customers
Not tracked yet Pharmaceutical Companies, Biotech Research Organizations, Healthcare Providers
Taxonomy
Biopharmaceutical, Antibody Therapeutics, Oncology, Immunology, Novel Antibody Discovery, Harbour Mice® Platform, Monoclonal Antibodies, Heavy Chain Only Antibodies, Immune Cell Engagers, HBICE® Technology, Transgenic Mouse Platforms, B-cell Cloning, Immuno-oncology, Inflammatory Diseases, Drug Discovery And Development Therapeutic Antibodies, Drug Discovery, Robotic Automation, Synthetic Biology, Protein Therapeutics, Antibody Engineering, Solid Tumors, Biopharmaceutical, Selectivity-enhanced Antibodies, Protein Engineering Platform, Antibody Therapeutics, Evolution Engine
Website
harbourbiomed.com labgeniustx.com
Harbour BioMed logo

About Harbour BioMed

Harbour BioMed, operating under the slogan "Healthy Life · Breakthrough Medicines," is a dynamic player in the global biopharmaceutical landscape. Established in 2016, the company has rapidly developed a strong foundation in oncology and immunology through innovative antibody therapeutics. This Uni...

LabGenius Therapeutics logo

About LabGenius Therapeutics

LabGenius Therapeutics, founded in 2012, is a drug discovery company based in the United Kingdom. It focuses on the development of next-generation therapeutic antibodies utilizing its advanced EVA™ platform, which combines artificial intelligence, robotic automation, and synthetic biology. This plat...

We will tell you when either one moves

BounceWatch watches Harbour BioMed and LabGenius Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Harbour BioMed and LabGenius Therapeutics — by email.

Frequently Asked Questions

Harbour BioMed — Healthy Life · Breakthrough Medicines. LabGenius Therapeutics — Combining human and machine intelligence to discover the next generation of therapeutic antibodies. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Harbour BioMed has raised $533.80M while LabGenius Therapeutics has raised $63.66M.
Harbour BioMed and LabGenius Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Harbour BioMed with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Harbour BioMed on 15 Jun 2026, and LabGenius Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy